Enrico Frigoli

发表

Abbreviated Antiplatelet Therapy in Patients at High Bleeding Risk With or Without Oral Anticoagulant Therapy After Coronary Stenting

A. Íñiguez, P. Jüni, S. Windecker, 2021, Circulation.

Scientific Foundation and Possible Implications for Practice of the Minimizing Adverse Haemorrhagic Events by Transradial Access Site and Systemic Implementation of AngioX (MATRIX) Trial

M. Valgimigli, A. Santarelli, C. Briguori, 2014, Journal of Cardiovascular Translational Research.

Bivalirudin or Unfractionated Heparin in Acute Coronary Syndromes.

P. Jüni, M. Valgimigli, A. Santarelli, 2015, The New England journal of medicine.

Radial versus femoral access in patients with acute coronary syndromes undergoing invasive management: a randomised multicentre trial

Sunil V. Rao, P. Jüni, M. Valgimigli, 2015, The Lancet.

Post-Procedural Bivalirudin Infusion at Full or Low Regimen in Patients With Acute Coronary Syndrome.

S. Windecker, M. Valgimigli, A. Santarelli, 2019, Journal of the American College of Cardiology.

Assessment of residual thrombus burden in patients with ST‐segment elevation myocardial infarction undergoing bivalirudin versus unfractionated heparin infusion: The MATRIX (minimizing adverse hemorrhagic events by transradial access site and angioX) OCT study

M. Valgimigli, C. Briguori, F. Varbella, 2019, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

SINUS BRADYCARDIA AS THE INITIAL MANIFESTATION OF COVID-19

S. Windecker, M. Valgimigli, G. Esposito, 2021, Journal of the American College of Cardiology.

Acute Kidney Injury After Radial or Femoral Access for Invasive Acute Coronary Syndrome Management: AKI-MATRIX.

S. de Servi, P. Jüni, S. Windecker, 2017, Journal of the American College of Cardiology.

Impact of Sex on Comparative Outcomes of Radial Versus Femoral Access in Patients With Acute Coronary Syndromes Undergoing Invasive Management: Data From the Randomized MATRIX-Access Trial.

S. Windecker, M. Valgimigli, A. Santarelli, 2018, JACC. Cardiovascular interventions.

Choice of access site and type of anticoagulant in acute coronary syndromes with advanced Killip class or out-of-hospital cardiac arrest.

S. Windecker, M. Valgimigli, G. Esposito, 2020, Revista espanola de cardiologia.

Radiation Exposure and Vascular Access in Acute Coronary Syndromes: The RAD-Matrix Trial.

P. Jüni, S. Windecker, M. Valgimigli, 2017, Journal of the American College of Cardiology.

Bivalirudin or Heparin in Patients Undergoing Invasive Management of Acute Coronary Syndromes.

S. Windecker, M. Valgimigli, A. Santarelli, 2018, Journal of the American College of Cardiology.

Radial versus femoral access and bivalirudin versus unfractionated heparin in invasively managed patients with acute coronary syndrome (MATRIX): final 1-year results of a multicentre, randomised controlled trial

E. Bramucci, E. D. Lorenzo, E. Romagnoli, 2018, The Lancet.

Design and rationale of the Management of High Bleeding Risk Patients Post Bioresorbable Polymer Coated Stent Implantation With an Abbreviated Versus Standard DAPT Regimen (MASTER DAPT) Study

A. Íñiguez, J. Tijssen, P. Jüni, 2019, American heart journal.

Radial versus femoral access in patients with acute coronary syndromes with or without ST-segment elevation

P. Jüni, S. Windecker, M. Valgimigli, 2017, European heart journal.

OCT Appraisal of Residual Thrombus Burden in Patients With STEMI Undergoing Intraprocedural Versus Post-Stenting Prolonged Bivalirudin Infusion: The MATRIX OCT Study.

M. Valgimigli, C. Briguori, F. Varbella, 2019, JACC. Cardiovascular imaging.

Comparison of intra-procedural vs. post-stenting prolonged bivalirudin infusion for residual thrombus burden in patients with ST-segment elevation myocardial infarction undergoing: the MATRIX (Minimizing Adverse Haemorrhagic Events by TRansradial Access Site and angioX) OCT study.

M. Valgimigli, C. Briguori, F. Varbella, 2019, European heart journal cardiovascular Imaging.

Impact of Medication Nonadherence in a Clinical Trial of Dual Antiplatelet Therapy.

S. Windecker, M. Valgimigli, P. Smits, 2022, Journal of the American College of Cardiology.

Dual Antiplatelet Therapy after PCI in Patients at High Bleeding Risk.

A. Íñiguez, P. Jüni, S. Windecker, 2021, The New England journal of medicine.

Acute kidney injury in patients with acute coronary syndrome undergoing invasive management treated with bivalirudin vs. unfractionated heparin: insights from the MATRIX trial.

P. Jüni, S. Windecker, M. Valgimigli, 2021, European heart journal. Acute cardiovascular care.

Access-Site Crossover in Patients With Acute Coronary Syndrome Undergoing Invasive Management.

S. Windecker, M. Valgimigli, G. Esposito, 2021, JACC. Cardiovascular interventions.

Impact of optical coherence tomography findings on clinical outcomes in ST-segment elevation myocardial infarction patients: a MATRIX (Minimizing Adverse Hemorrhagic Events by Trans-radial Access Site and angioX) OCT sub-study

M. Valgimigli, C. Briguori, F. Varbella, 2020, The International Journal of Cardiovascular Imaging.

Femoral Access With or Without Vascular Closure Device or Radial Access in Acute Coronary Syndrome.

S. Windecker, M. Valgimigli, P. Calabrò, 2019, JACC. Cardiovascular interventions.

Impact of sex on comparative outcomes of bivalirudin versus unfractionated heparin in patients with acute coronary syndromes undergoing invasive management: a pre-specified analysis of the MATRIX trial.

S. de Servi, S. Windecker, M. Valgimigli, 2019, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Determinants of radiation dose during right transradial access: Insights from the RAD‐MATRIX study

M. Valgimigli, P. Calabrò, G. Sardella, 2018, American heart journal.

Radiation Exposure and Vascular Access in Acute Coronary Syndromes: A Randomised Multicentre Trial

P. Jüni, S. Windecker, M. Valgimigli, 2022 .

Radiation Exposure and Vascular Access€in€Acute Coronary Syndromes

P. Jüni, S. Windecker, M. Valgimigli, 2022 .

Abbreviated Antiplatelet Therapy After Coronary Stenting in Patients With Myocardial Infarction at High Bleeding Risk.

A. Íñiguez, S. Windecker, M. Valgimigli, 2022, Journal of the American College of Cardiology.

This appendix has been provided by the authors to give readers additional information about their work.

Roberto Garbo, Carlo Briguori, Peter Jüni, 2015 .

ECG analysis in patients with acute coronary syndrome undergoing invasive management: rationale and design of the electrocardiography sub-study of the MATRIX trial.

S. Windecker, M. Valgimigli, M. Cimmino, 2019, Journal of electrocardiology.

Duration of Antiplatelet Therapy After Complex Percutaneous Coronary Intervention In Patients at High Bleeding Risk: a MASTER DAPT trial sub-analysis.

M. Valgimigli, P. Smits, D. Heg, 2022, European heart journal.

Bivalirudin or unfractionated heparin in patients with acute coronary syndromes managed invasively with and without ST elevation (MATRIX): randomised controlled trial

S. Windecker, M. Valgimigli, C. Briguori, 2016, British Medical Journal.

Individual Patient Data Pooled Analysis of Randomized Trials of Bivalirudin versus Heparin in Acute Myocardial Infarction: Rationale and Methodology

G. Stone, A. Kastrati, R. Mehran, 2019, Thrombosis and Haemostasis.

Prediction of radial crossover in acute coronary syndromes: derivation and validation of the MATRIX score.

D. van Klaveren, E. Romagnoli, G. Biondi-Zoccai, 2021, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Abbreviated or Standard Antiplatelet Therapy in HBR Patients: Final 15-Month Results of the MASTER-DAPT Trial.

S. Cook, S. Windecker, M. Valgimigli, 2023, JACC. Cardiovascular interventions.

Association of acute kidney injury and bleeding events with mortality after radial or femoral access in patients with acute coronary syndrome undergoing invasive management: secondary analysis of a randomized clinical trial

E. Romagnoli, M. Valgimigli, F. Amico, 2019, European heart journal.

Acute kidney injury after percutaneous coronary intervention: Rationale of the AKI‐MATRIX (acute kidney injury‐minimizing adverse hemorrhagic events by TRansradial access site and systemic implementation of angioX) sub‐study

M. Valgimigli, C. Briguori, P. Calabrò, 2015, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Irrigated-tip magnetic catheter ablation of AF: a long-term prospective study in 130 patients.

V. Santinelli, C. Pappone, G. Vicedomini, 2011, Heart rhythm.

Reproducibility of an artificial intelligence optical coherence tomography software for tissue characterization: Implications for the design of longitudinal studies.

H. Garcia-Garcia, M. Valgimigli, C. Briguori, 2023, Cardiovascular revascularization medicine : including molecular interventions.

Validation of a Contemporary Acute Kidney Injury Risk Score in Patients With Acute Coronary Syndrome.

M. Valgimigli, C. Briguori, G. Esposito, 2023, JACC. Cardiovascular interventions.

Effects of Ticagrelor, Prasugrel, or Clopidogrel on Endothelial Function and Other Vascular Biomarkers: A Randomized Crossover Study.

L. Räber, S. Windecker, S. Rimoldi, 2018, JACC. Cardiovascular interventions.